A detailed history of California State Teachers Retirement System transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 2,275 shares of DSGN stock, worth $13,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,275
Previous 2,275 -0.0%
Holding current value
$13,695
Previous $7,000 71.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.23 - $4.77 $3,291 - $4,860
-1,019 Reduced 30.94%
2,275 $7,000
Q1 2024

May 15, 2024

SELL
$2.27 - $4.03 $4,767 - $8,463
-2,100 Reduced 38.93%
3,294 $13,000
Q4 2023

Feb 13, 2024

SELL
$1.99 - $2.76 $3,655 - $5,070
-1,837 Reduced 25.4%
5,394 $14,000
Q3 2023

Nov 14, 2023

SELL
$2.05 - $8.14 $7,523 - $29,873
-3,670 Reduced 33.67%
7,231 $17,000
Q2 2023

Aug 21, 2023

SELL
$4.99 - $7.64 $8,468 - $12,965
-1,697 Reduced 13.47%
10,901 $68,000
Q1 2023

May 09, 2023

SELL
$5.5 - $9.77 $5,109 - $9,076
-929 Reduced 6.87%
12,598 $72,000
Q4 2022

Feb 14, 2023

BUY
$7.86 - $17.2 $1,202 - $2,631
153 Added 1.14%
13,527 $138,000
Q3 2022

Nov 18, 2022

SELL
$14.09 - $25.57 $15,710 - $28,510
-1,115 Reduced 7.7%
13,374 $224,000
Q2 2022

Aug 15, 2022

BUY
$9.91 - $17.33 $30,334 - $53,047
3,061 Added 26.79%
14,489 $203,000
Q1 2022

May 16, 2022

SELL
$11.17 - $20.89 $34,548 - $64,612
-3,093 Reduced 21.3%
11,428 $185,000
Q4 2021

Feb 15, 2022

BUY
$13.64 - $21.41 $99,285 - $155,843
7,279 Added 100.51%
14,521 $311,000
Q3 2021

Nov 15, 2021

SELL
$13.99 - $20.03 $158,884 - $227,480
-11,357 Reduced 61.06%
7,242 $106,000
Q2 2021

Aug 16, 2021

BUY
$19.02 - $29.78 $353,752 - $553,878
18,599 New
18,599 $370,000

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $336M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.